IP Library Assignment 052217/0461
Patent Assignment
Reel/Frame 052217/0461

Corrective Assignment to Correct the Correct Application Number Previously Recorded at Reel: 052065 Frame: 0156. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2020-03-24 Pages: 8
Assignors
AERTS, LUC LAMBERT JOZEF JAN
Executed: 2020-01-23
ASSAF, GEORGES
Executed: 2020-02-11
CARLY, NICOLAS EDMOND
Executed: 2020-02-11
COOL, VINCENT ADOLPHE CAROL
Executed: 2020-01-23
DELATINNE, JEAN-PIERRE
Executed: 2020-01-23
DELHAYE, LAURENT JACQUES WILLY
Executed: 2020-02-10
KESTEMONT, JEAN PAUL
Executed: 2020-01-23
LE MEUR, SARAH
Executed: 2020-01-23
Assignee
UCB BIOPHARMA SPRL
ALLEE DE LA RECHERCHE 60, BRUSSELS, B-1070, BELGIUM
Covered Property (1)
Crystalline Forms of Seletalisib
Application: 16/615,992 →
Publication: US 2020/0095246
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name May 25, 2021
From: UCB BIOPHARMA SPRL (SOCIETE PRIVEE A RESPONSABILITIE LIMITEE)
To: UCB BIOPHARMA SRL (SOCIETE A RESPONSABILITE LIMITEE)
Reel/Frame 056367/0432 →